NCT00027924View on ClinicalTrials.gov

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2001

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
LeukemiaMyelodysplastic Syndromes
Interventions
DRUG

busulfan

DRUG

cyclosporine

DRUG

fludarabine phosphate

DRUG

methotrexate

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00027924 - Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter